OSAKA, Japan & CAMBRIDGE, Mass. & NEWARK, Calif. Takeda (TSE:4502/NYSE:TAK) and Protagonist Therapeutics (Nasdaq: PTGX) (“Protagonist”) announced the submission of a New Drug Application (NDA) to the ...
Back in 1993, WIRED’s founders published a manifesto offering some guidance. “Our first instruction to our writers: Amaze us … tell us something we've never heard before, in a way we've never seen ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果